• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白对Caco-2细胞中吗啡转运的影响。与紫杉醇的比较。

The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel.

作者信息

Crowe Andrew

机构信息

School of Pharmacy, Curtin University of Technology, GPO Box U1987, 6845, Perth, Australia.

出版信息

Eur J Pharmacol. 2002 Apr 5;440(1):7-16. doi: 10.1016/s0014-2999(02)01366-3.

DOI:10.1016/s0014-2999(02)01366-3
PMID:11959083
Abstract

In vitro monolayer studies using Caco-2 cells were employed here to explore P-glycoprotein mediated transport of morphine. Bi-directional transport studies of 10-75 microM morphine showed efflux to be twofold higher than influx (4 x 10(-6) compared to 2 x 10(-6) cm/s) and cellular accumulation in the efflux direction was eightfold higher. The cyclosporin analogue (PSC-833) equilibrated morphine transport in both directions. Depletion of intracellular glutathione had a greater effect on increasing cellular morphine accumulation than P-glycoprotein inhibitors, suggesting a role for glutathione in morphine transport. P-glycoprotein had a substantially greater effect on paclitaxel accumulation, efflux and bi-directional transport than for morphine. Paclitaxel transport was below detection (<0.1 x 10(-6) cm/s) in the influx direction, yet efflux was very high (18.4 x 10(-6) cm/s) and P-glycoprotein inhibition increased accumulation >100-fold. These results reinforce the substantial role P-glycoprotein has in paclitaxel transport. Conversely, P-glycoprotein regulated morphine transport is weak. Nevertheless, morphine transport rates could be doubled when administered with P-glycoprotein substrates. Therefore, increased analgesia through P-glycoprotein inhibition should be possible.

摘要

本研究采用Caco - 2细胞进行体外单层研究,以探讨P - 糖蛋白介导的吗啡转运。对10 - 75 μM吗啡的双向转运研究表明,外流转运比内流转运高两倍(外流转运速率为4×10⁻⁶ cm/s,内流转运速率为2×10⁻⁶ cm/s),且外流转运方向的细胞蓄积高八倍。环孢素类似物(PSC - 833)使吗啡在两个方向上的转运达到平衡。细胞内谷胱甘肽的耗竭对增加细胞吗啡蓄积的影响比P - 糖蛋白抑制剂更大,表明谷胱甘肽在吗啡转运中发挥作用。P - 糖蛋白对紫杉醇蓄积、外流转运和双向转运的影响比对吗啡的影响大得多。紫杉醇的内流转运低于检测限(<0.1×10⁻⁶ cm/s),但其外流转运非常高(18.4×10⁻⁶ cm/s),P - 糖蛋白抑制使紫杉醇蓄积增加>100倍。这些结果强化了P - 糖蛋白在紫杉醇转运中的重要作用。相反,P - 糖蛋白对吗啡转运的调节作用较弱。然而,与P - 糖蛋白底物一起给药时,吗啡转运速率可提高一倍。因此,通过抑制P - 糖蛋白来增强镇痛效果应该是可行的。

相似文献

1
The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel.P-糖蛋白对Caco-2细胞中吗啡转运的影响。与紫杉醇的比较。
Eur J Pharmacol. 2002 Apr 5;440(1):7-16. doi: 10.1016/s0014-2999(02)01366-3.
2
Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.阿托伐他汀在Caco-2细胞模型中的转运:P-糖蛋白和质子-单羧酸共转运体的作用
Pharm Res. 2000 Feb;17(2):209-15. doi: 10.1023/a:1007525616017.
3
Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.吗啡、芬太尼、舒芬太尼、阿芬太尼和洛哌丁胺与外排药物转运体P-糖蛋白的相互作用。
Anesthesiology. 2002 Apr;96(4):913-20. doi: 10.1097/00000542-200204000-00019.
4
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.多药耐药逆转剂MS-209对P-糖蛋白的抑制作用增强了口服紫杉醇的生物利用度和抗肿瘤疗效。
Cancer Chemother Pharmacol. 2002 Apr;49(4):322-8. doi: 10.1007/s00280-001-0419-x. Epub 2002 Feb 1.
5
Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport.P-糖蛋白和钙通道在洛哌丁胺和地芬诺酯转运中的潜在作用。
Toxicol Appl Pharmacol. 2003 Nov 15;193(1):127-37. doi: 10.1016/s0041-008x(03)00372-7.
6
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells.P-糖蛋白介导的吗啡在脑毛细血管内皮细胞中的转运。
Biochem Pharmacol. 1999 Sep 15;58(6):951-7. doi: 10.1016/s0006-2952(99)00180-x.
7
Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.多药耐药逆转剂对转染了 Gly(185)-->Val 人 P-糖蛋白的 KB3-1 细胞的活性改变。
Int J Oncol. 2000 Sep;17(3):579-86. doi: 10.3892/ijo.17.3.579.
8
Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.多西他赛和长春碱在人肠上皮细胞单层中由P-糖蛋白介导的极化转运。
Biochem Pharmacol. 1994 Oct 7;48(7):1528-30. doi: 10.1016/0006-2952(94)90580-0.
9
P-glycoprotein efflux pump expression and activity in Calu-3 cells.P-糖蛋白外排泵在Calu-3细胞中的表达及活性
J Pharm Sci. 2001 May;90(5):647-58. doi: 10.1002/1520-6017(200105)90:5<647::aid-jps1021>3.0.co;2-g.
10
Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.两种环孢素衍生物(PSC 833)和环孢素A在人结肠腺癌HCT-15亚系中的细胞内水平与多药耐药调节活性密切相关。
Jpn J Cancer Res. 2001 Oct;92(10):1116-26. doi: 10.1111/j.1349-7006.2001.tb01067.x.

引用本文的文献

1
Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?用于体内P-糖蛋白底物脑细胞外液药代动力学机制预测的体外数据的可靠性;我们的缩放是否正确?
J Pharmacokinet Pharmacodyn. 2025 Feb 8;52(2):16. doi: 10.1007/s10928-025-09963-w.
2
PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans.用于预测吗啡药代动力学、CNS 效应和纳洛酮拮抗作用的 PBPK-PD 模型在人体中的应用。
Acta Pharmacol Sin. 2024 Aug;45(8):1752-1764. doi: 10.1038/s41401-024-01255-2. Epub 2024 Apr 3.
3
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival.
用PARP抑制剂靶向卵巢癌中的同源重组缺陷:影响总生存期的合成致死策略
Cancers (Basel). 2022 Sep 23;14(19):4621. doi: 10.3390/cancers14194621.
4
Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats.索拉非尼与吗啡在大鼠体内的药代动力学药物相互作用研究
Pharmaceutics. 2021 Dec 16;13(12):2172. doi: 10.3390/pharmaceutics13122172.
5
Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.阿片类药物与血脑屏障:一种动态相互作用,对脑内药物处置有影响。
Curr Neuropharmacol. 2017 Nov 14;15(8):1156-1173. doi: 10.2174/1570159X15666170504095823.
6
Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.药物相互作用中 P-糖蛋白调节的临床意义。
Drugs. 2017 May;77(8):859-883. doi: 10.1007/s40265-017-0729-x.
7
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).药物研发中清除机制的预测:扩展清除分类系统(ECCS)。
Pharm Res. 2015 Dec;32(12):3785-802. doi: 10.1007/s11095-015-1749-4. Epub 2015 Jul 9.
8
Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.转运体介导的阿片类药物处置:对临床药物相互作用的影响
Pharm Res. 2015 Aug;32(8):2477-502. doi: 10.1007/s11095-015-1711-5. Epub 2015 May 14.
9
Sensitivity and mechanisms of taxol-resistant prostate adenocarcinoma cells to Vernonia amygdalina extract.紫杉醇耐药前列腺腺癌细胞对扁桃斑鸠菊提取物的敏感性及机制
Exp Toxicol Pathol. 2013 Sep;65(6):759-65. doi: 10.1016/j.etp.2012.11.002. Epub 2012 Dec 11.
10
Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.阿片类镇痛药和 P-糖蛋白外排转运蛋白:对镇痛耐受的潜在系统水平贡献。
Curr Top Med Chem. 2011;11(9):1157-64. doi: 10.2174/156802611795371288.